Clinical Trials · NCT07064486
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- BrightGene Bio-Medical Technology Co., Ltd.
- Enrollment
- 477
- Start date
- Jul 2025
- Locations
- 4 sites, Indonesia
- Primary endpoint
- Change From Baseline in Hemoglobin A1c (HbA1c)